BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18855682)

  • 1. Design, synthesis and anticancer activity against the MCF-7 cell line of benzo-fused 1,4-dihetero seven- and six-membered tethered pyrimidines and purines.
    Núñez MC; Díaz-Gavilán M; Conejo-García A; Cruz-López O; Gallo MA; Espinosa A; Campos JM
    Curr Med Chem; 2008; 15(25):2614-31. PubMed ID: 18855682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies.
    Díaz-Gavilán M; Gómez-Vidal JA; Rodríguez-Serrano F; Marchal JA; Caba O; Aránega A; Gallo MA; Espinosa A; Campos JM
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1457-60. PubMed ID: 18194866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From 5-fluorouracil acyclonucleosides to benzo-fused six- and seven-membered rings linked to pyrimidine and purine bases: the shift from differentiating anticancer agents to apoptotic inducers.
    Conejo-García A; Núñez Mdel C; Díaz-Gavilán M; Cruz-López O; Gallo MÁ; Espinosa A; Campos JM
    Expert Opin Drug Discov; 2008 Oct; 3(10):1223-35. PubMed ID: 23489079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and anticancer activity of (R,S)-9-(2,3-dihydro-1,4-benzoxathiin-3-ylmethyl)-9H-purines.
    Díaz-Gavilán M; Conejo-García A; Cruz-López O; Núñez MC; Choquesillo-Lazarte D; González-Pérez JM; Rodríguez-Serrano F; Marchal JA; Aránega A; Gallo MA; Espinosa A; Campos JM
    ChemMedChem; 2008 Jan; 3(1):127-35. PubMed ID: 18022976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer activity and cDNA microarray studies of a (RS)-1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl]-6-chloro-9H-purine, and an acyclic (RS)-O,N-acetalic 6-chloro-7H-purine.
    Caba O; Díaz-Gavilán M; Rodríguez-Serrano F; Boulaiz H; Aránega A; Gallo MA; Marchal JA; Campos JM
    Eur J Med Chem; 2011 Sep; 46(9):3802-9. PubMed ID: 21684047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and anticancer activity of (RS)-9-(2,3-dihydro-1,4-benzoxaheteroin-2-ylmethyl)-9H-purines.
    Conejo-García A; García-Rubiño ME; Marchal JA; Núñez MC; Ramírez A; Cimino S; García MÁ; Aránega A; Gallo MA; Campos JM
    Eur J Med Chem; 2011 Sep; 46(9):3795-801. PubMed ID: 21645946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New medium oxacyclic O,N-acetals and related open analogues: biological activities.
    Campos J; Saniger E; Marchal JA; Aiello S; Súarez I; Boulaiz H; Aránega A; A Gallo M; Espinosa A
    Curr Med Chem; 2005; 12(12):1423-38. PubMed ID: 15974993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumoural properties of benzannelated seven-membered 5-fluorouracil derivatives and related open analogues. Molecular markers for apoptosis and cell cycle dysregulation.
    Espinosa A; Marchal JA; Aránega A; Gallo MA; Aiello S; Campos J
    Farmaco; 2005 Feb; 60(2):91-7. PubMed ID: 15752467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New (RS)-benzoxazepin-purines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine.
    López-Cara LC; Conejo-García A; Marchal JA; Macchione G; Cruz-López O; Boulaiz H; García MA; Rodríguez-Serrano F; Ramírez A; Cativiela C; Jiménez AI; García-Ruiz JM; Choquesillo-Lazarte D; Aránega A; Campos JM
    Eur J Med Chem; 2011 Jan; 46(1):249-58. PubMed ID: 21126804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regiospecific microwave-assisted synthesis and cytotoxic activity against human breast cancer cells of (RS)-6-substituted-7- or 9-(2,3-dihydro-5H-1,4-benzodioxepin-3-yl)-7H- or -9H-purines.
    Conejo-García A; Núñez MC; Marchal JA; Rodríguez-Serrano F; Aránega A; Gallo MA; Espinosa A; Campos JM
    Eur J Med Chem; 2008 Aug; 43(8):1742-8. PubMed ID: 18069093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and anticancer activity of fluorocyclopentenyl-purines and - pyrimidines.
    Yoon JS; Jarhad DB; Kim G; Nayak A; Zhao LX; Yu J; Kim HR; Lee JY; Mulamoottil VA; Chandra G; Byun WS; Lee SK; Kim YC; Jeong LS
    Eur J Med Chem; 2018 Jul; 155():406-417. PubMed ID: 29906687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-proliferative activity of 2,6-dichloro-9- or 7-(ethoxycarbonylmethyl)-9H- or 7H-purines against several human solid tumour cell lines.
    Morales F; Ramírez A; Conejo-García A; Morata C; Marchal JA; Campos JM
    Eur J Med Chem; 2014 Apr; 76():118-24. PubMed ID: 24583351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Dynamics and Biological Evaluation of 2-chloro-7-cyclopentyl- 7H-pyrrolo[2,3-d]pyrimidine Derivatives Against Breast Cancer.
    Singaram K; Marimuthu D; Baskaran S; Chinaga SK; Shanmugarajan D; Vadivel T
    Comb Chem High Throughput Screen; 2017; 20(8):703-712. PubMed ID: 28738766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells.
    Marchal JA; Núñez MC; Suárez I; Díaz-Gavilán M; Gómez-Vidal JA; Boulaiz H; Rodríguez-Serrano F; Gallo MA; Espinosa A; Aránega A; Campos JM
    Breast Cancer Res Treat; 2007 Nov; 105(3):237-46. PubMed ID: 17124554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of 2,6-disubstituted-9H-purine, 2,4-disubstitued-thieno[3,2-d]pyrimidine and -7H-pyrrolo[2,3-d]pyrimidine analogues as novel CHK1 inhibitors.
    Tian C; Han Z; Li Y; Wang M; Yang J; Wang X; Zhang Z; Liu J
    Eur J Med Chem; 2018 May; 151():836-848. PubMed ID: 29684894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyclonucleosides, modified seco-nucleosides, and salicyl- or catechol-derived acyclic 5-fluorouracil O,N-acetals: antiproliferative activities, cellular differentiation and apoptosis.
    Marchal JA; Núñez MC; Aránega A; Gallo MA; Espinosa A; Campos JM
    Curr Med Chem; 2009; 16(9):1166-83. PubMed ID: 19275619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel heterocyclic-fused pyrimidine derivatives: synthesis, molecular modeling and pharmacological screening.
    Arafa RK; Nour MS; El-Sayed NA
    Eur J Med Chem; 2013 Nov; 69():498-507. PubMed ID: 24090920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. From a classic approach in cancer chemotherapy towards differentiation therapy: acyclic and cyclic seven-membered 5-fluorouracil O,N-acetals.
    Campos J; Domínguez JF; Gallo MA; Espinosa A
    Curr Pharm Des; 2000 Dec; 6(18):1797-810. PubMed ID: 11102563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroidal[17,16-d]pyrimidines derived from dehydroepiandrosterone: A convenient synthesis, antiproliferation activity, structure-activity relationships, and role of heterocyclic moiety.
    Ke S; Shi L; Zhang Z; Yang Z
    Sci Rep; 2017 Mar; 7():44439. PubMed ID: 28290501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and antiproliferative activity of novel 5-nitropyrimidine-2,4-diamine derivatives bearing alkyl acetate moiety.
    Zhao PL; Li YH; Yang HK; Chen P; Zhang B; Sun Q; Li Q; You WW
    Eur J Med Chem; 2016 Aug; 118():161-9. PubMed ID: 27128180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.